A novel deconvolution method for modeling UDP-N-acetyl-D-glucosamine biosynthetic pathways based on 13C mass isotopologue profiles under non-steady-state conditions

BMC Biology

Volumn 9, Issue , 2011, Pages

  Moseley, Hunter N B ^a   Lane, Andrew N ^a,b   Belshoff, Alex C ^b   Higashi, Richard M ^a   Fan, Teresa W M ^a,b  

^a UNIVERSITY OF LOUISVILLE   (United States)

^b University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; GLUCOSE; RIBOSE; URACIL; URIDINE DIPHOSPHATE N ACETYLGLUCOSAMINE;

ALGORITHM; ARTICLE; BIOSYNTHESIS; CHEMISTRY; CYCLOTRON; EVALUATION; FOURIER ANALYSIS; HUMAN; ISOTOPE LABELING; MASS SPECTROMETRY; METABOLISM; METABOLOMICS; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; TUMOR CELL LINE;

ALGORITHMS; BIOSYNTHETIC PATHWAYS; CARBON ISOTOPES; CELL LINE, TUMOR; CYCLOTRONS; FOURIER ANALYSIS; GLUCOSE; HUMANS; ISOTOPE LABELING; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; METABOLOMICS; RIBOSE; URACIL; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE;

EID: 79957630849     PISSN: None     EISSN: 17417007     Source Type: Journal    
DOI: 10.1186/1741-7007-9-37     Document Type: Article

References (45)

1. Marin S, Lee WNP, Bassilian S, Lim S, Boros LG, Centelles JJ, Fernandez-Novell JM, Guinovart JJ, Cascante M. Dynamic profiling of the glucose metabolic network in fasted rat hepatocytes using 1,2-C-13(2) glucose. Biochem J 2004, 381:287-294. 10.1042/BJ20031737, 1133787, 15032751.
2. Des Rosiers C, Lloyd S, Comte B, Chatham JC. A critical perspective of the use of C-13-isotopomer analysis by GCMS and NMR as applied to cardiac metabolism. Metabol Eng 2004, 6:44-58.
3. Fan TWM, Lane AN, Higashi RM. The promise of metabolomics in cancer molecular therapeutics. Curr Opin Mol Ther 2004, 6:584-592.
4. DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB. Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci USA 2007, 104:19345-19350. 10.1073/pnas.0709747104, 2148292, 18032601.
5. Lane AN, Fan TW-M, Xie X, Moseley HN, Higashi RM. Stable isotope analysis of lipid biosynthesis by high resolution mass spectrometry and NMR. Anal Chim Acta 2009, 651:201-208. 10.1016/j.aca.2009.08.032, 2757635, 19782812.
6. Fan TW-M, Lane AN, Higashi RM, Farag MA, Gao H, Bousamra M, Miller DM. Altered regulation of metabolic pathways in human lung cancer discerned by 13C stable isotope-resolved metabolomics (SIRM)). Mol Cancer 2009, 8:41. 10.1186/1476-4598-8-41, 2717907, 19558692.
7. Lane AN, Fan TW-M, Higashi RM. Stable isotope assisted metabolomics in cancer research. IUBMB Life 2008, 60:124-129. 10.1002/iub.17, 18380001.
8. Lane AN, Fan TW-M, Higashi RM. Isotopomer-based metabolomic analysis by NMR and mass spectrometry. Biophys Tools Biol 2008, 84:541-588.
9. Fan TW-M, Kucia M, Jankowski K, Higashi RM, Rataczjak MZ, Rataczjak J, Lane AN. Proliferating rhabdomyosarcoma cells shows an energy producing anabolic metabolic phenotype compared with primary myocytes. Mol Cancer 2008, 7:79. 2577687, 18939998.
10. Fan TW-M, Lane AN. Structure-based profiling of metabolites and isotopomers by NMR. Prog NMR Spectr 2008, 52:69-117.
11. Lane AN, Fan TW-M. Quantification and identification of isotopomer distributions of metabolites in crude cell extracts using 1H TOCSY. Metabolomics 2007, 3:79-86.
12. Fan TW-M, Bandura L, Higashi RM, Lane AN. Metabolomics-edited transcriptomics analysis of Se anticancer action in human lung cancer cells. Metabolomics 2005, 1:1-15.
13. Fan TWM, Higashi RM, Lane AN, Jardetzky O. Combined use of proton NMR and gas chromatography-mass spectra for metabolite monitoring and in vivo proton NMR assignments. Biochim Biophys Acta 1986, 882:154-167.
14. Murray KM. Glycoproteins. Harper's Illustrated Biochemistry 2009, New York: McGraw-Hill, 28.
15. Taylor RP, Geisler TS, Chambers JH, McClain DA. Up-regulation of O-GlcNAc transferase with glucose deprivation in HepG2 cells is mediated by decreased hexosamine pathway flux. J Biol Chem 2009, 284:3425-3432. 2635029, 19073609.
16. Hanover JA, Krause MW, Love DC. The hexosamine signaling pathway O-GlcNAc cycling in feast or famine. Biochim Biophys Acta 2010, 1800:80-95. 2815088, 19647043.
17. Stanley P, Schachter H, Taniguchi N. N-Glycans. Essentials of Glycobiology 2009, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, Varki A, Cummings RD, Esko JD, Freeze HH, Stanley P, Bertozzi CR, Hart GW, Etzler ME, 2.
18. Lau KS, Khan S, Dennis JW. Genome-scale identification of UDP-GlcNAc-dependent pathways. Proteomics 2008, 8:3294-3302. 10.1002/pmic.200800208, 18646010.
19. Clarke AJ, Hurtado-Guerrero R, Pathak S, Schuttelkopf AW, Borodkin V, Shepherd SM, Ibrahim AFM, van Aalten DMF. Structural insights into mechanism and specificity of O-GlcNAc transferase. EMBO J 2008, 27:2780-2788. 10.1038/emboj.2008.186, 2556091, 18818698.
20. Zachara NE, Hart GW. O-GlcNAc a sensor of cellular state: the role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 2004, 1673:13-28.
21. Gambetta MC, Oktaba K, Muller J. Essential role of the glycosyltransferase Sxc/Ogt in polycomb repression. Science 2009, 325:93-96. 10.1126/science.1169727, 19478141.
22. Morrish F, Isern N, Sadilek M, Jeffrey M, Hockenbery DM. c-Myc activates multiple metabolic networks to generate substrates for cell-cycle entry. Oncogene 2009, 28:2485-2491. 10.1038/onc.2009.112, 2779836, 19448666.
23. Villa R, Pasini D, Gutierrez A, Morey L, Occhionorelli M, Viré E, Nomdedeu JF, Jenuwein T, Pelicci PG, Minucci S, Fuks F, Helin K, Di Croce L. Role of the polycomb repressive complex 2 in acute promyelocytic leukemia. Cancer Cell 2007, 11:513-525. 10.1016/j.ccr.2007.04.009, 17560333.
24. Zeidan Q, Hart GW. The intersections between O-GlcNAcylation and phosphorylation: implications for multiple signaling pathways. J Cell Sci 2010, 123:13-22. 10.1242/jcs.053678, 2794709, 20016062.
25. Fan TW-M, Lane AN. NMR-based stable isotope resolved metabolomics in systems biochemistry. J Biomolec NMR 2011, 49:267-280.
26. Mancuso A, Sharfstein ST, Tucker SN, Clark DS, Blanch HW. Examination Of primary metabolic pathways in a murine hybridoma with C-13 nuclear-magnetic-resonance spectroscopy. Biotechnol Bioeng 1994, 44:563-585. 10.1002/bit.260440504, 18618793.
27. Mancuso A, Zhu AZ, Beardsley NJ, Glickson JD, Wehrli S, Pickup S. Artificial tumor model suitable for monitoring P-31 and C-13 NMR spectroscopic changes during chemotherapy-induced apoptosis in human glioma cells. Magnetic Reson Med 2005, 54:67-78.
28. Macdonald JM, Kurhanewicz J, Dahiya R, Espanol MT, Chang LH, Goldberg B, James TL, Narayan P. Effect of glucose and confluency on phosphorus metabolites of perfused human prostatic adenocarcinoma cells as determined by P-31 MRS. Magnetic Reson Med 1993, 29:244-248.
29. Fell DA, Small JR. Fat synthesis in adipose-tissue - an examination of stoichiometric constraints. Biochem J 1986, 238:781-786. 1147204, 3800960.
30. Savinell JM, Palsson BO. Optimal selection of metabolic fluxes for in vivo measurement. 1. Development of mathematical-methods. J Theor Biol 1992, 155:201-214. 10.1016/S0022-5193(05)80595-8, 1453697.
31. Kauffman KJ, Prakash P, Edwards JS. Advances in flux balance analysis. Curr Opin Biotechnol 2003, 14:491-496. 10.1016/j.copbio.2003.08.001, 14580578.
32. Sauer U. Metabolic networks in motion: C-13-based flux analysis. Mol Syst Biol 2006, 2:62. 1682028, 17102807.
33. Fell D. Understanding the Control of Metabolism 1997, London, UK: Portland Pres.
34. Antoniewicz MR, Kraynie DF, Laffend LA, Gonzalez-Lergier J, Kelleher JK, Stephanopoulos G. Metabolic flux analysis in a nonstationary system: Fed-batch fermentation of a high yielding strain of E. coli producing 1,3-propanediol. Metabol Eng 2007, 9:277-292.
35. Selivanov VA, Marin S, Lee PWN, Cascante M. Software for dynamic analysis of tracer-based metabolomic data: estimation of metabolic fluxes and their statistical analysis. Bioinformatics 2006, 22:2806-2812. 10.1093/bioinformatics/btl484, 17000750.
36. Schellenberger J, Palsson BO. Use of randomized sampling for analysis of metabolic networks. J Biol Chem 2009, 284:5457-5461.
37. Lane AN, Fan TW-M, Bousamra II M, Higashi RM, Yan J, Miller DM. Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to non-small cell lung cancer. Omics 2011, 15:173-182. 10.1089/omi.2010.0088, 21329461.
38. Lane AN, Fan TW-M, Higashi RM, Tan J, Bousamra M, Miller DM. Prospects for clinical cancer metabolomics using stable isotope tracers. J Exp Molec Pathol 2009, 86:165-173.
39. Moseley H. Correcting for the effects of natural abundance in stable isotope resolved metabolomics experiments involving ultra-high resolution mass spectrometry. BMC Bioinformatics 2010, 11:139. 2848236, 20236542.
40. Moseley HNB, Higashi RM, Fan TW-M, Lane AN. Analysis of non-steady state stable isotope-resolved metabolism of UDP-GlcNAc and UDP-GalNAc. Proceedings of BIOINFORMATICS 2011. Rome, Italy 2011, 108-115. Funchal, Portugal: SciTePress.
41. Akaike H. A new look at the statistical model identification. IEEE Trans Auto Cont 1974, 19:716-723.
42. Rexach JE, Rogers CJ, Yu SH, Tao J, Sun YE, Hsieh-Wilson LC. Quantification of O-glycosylation stoichiometry and dynamics using resolvable mass tags. Nat Chem Biol 2010, 6:645-651. 2924450, 20657584.
43. Gu Y, Mi W, Ge Y, Liu H, Fan Q, Han C, Yang J, Han F, Lu X, Yu W. GlcNAcylation plays an essential role in breast cancer metastasis. Cancer Res 2010, 70:6344-6351. 10.1158/0008-5472.CAN-09-1887, 20610629.
44. Selivanov VA, Puigjaner J, Sillero A, Centelles JJ, Ramos-Montoya A, Lee PWN, Cascante M. An optimized algorithm for flux estimation from isotopomer distribution in glucose metabolites. Bioinformatics 2004, 20:3387-3397. 10.1093/bioinformatics/bth412, 15256408.
45. McKeehan WL. Glycolysis, glutaminolysis and cell-proliferation. Cell Biol Int Rep 1982, 6:635-650. 10.1016/0309-1651(82)90125-4, 6751566.